Autosomal dominant disease
MONDO:0000426Autosomal dominant form of disease.
Also known as: autosomal dominant disease or disorder, autosomal dominant hereditary disorder, autosomal dominant inherited disorder, disease or disorder, autosomal dominant, disease, autosomal dominant
699 clinical trials for this condition and its sub-types, 0 tagged with Autosomal dominant disease itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →Sub-types of Autosomal dominant disease
-
Neurofibromatosis 19 trials · 94 incl. sub-types
5 sub-types
- Neurofibromatosis type 1 73 trials Sub-types →
- NF2-related schwannomatosis 21 trials
- Schwannomatosis 3 trials Sub-types →
- Neurofibromatosis-Noonan syndrome 2 trials Sub-types →
- Neurofibromatosis, type IV, of Riccardi 0 trials
-
Lynch syndrome 81 trials · 83 incl. sub-types
5 sub-types
- Lynch syndrome 1 5 trials
- Lynch syndrome 2 3 trials
- Lynch syndrome 4 0 trials
- Lynch syndrome 5 0 trials
- Lynch syndrome 8 0 trials
-
7 sub-types
- Polycystic kidney disease 1 1 trial
- ALG9-associated autosomal dominant polycystic kidney disease 0 trials
- Polycystic kidney disease 2 0 trials
- Polycystic kidney disease 3 with or without polycystic liver disease 0 trials
- Polycystic kidney disease 6 with or without polycystic liver disease 0 trials
- Polycystic kidney disease 7 0 trials
- Polycystic kidney disease 8 0 trials
-
Tuberous sclerosis 41 trials · 44 incl. sub-types
2 sub-types
- Tuberous sclerosis 1 33 trials
- Tuberous sclerosis 2 2 trials
-
Hereditary breast ovarian cancer syndrome 35 trials · 38 incl. sub-types
2 sub-types
-
Early-onset autosomal dominant Alzheimer disease 31 trials · 37 incl. sub-types
14 sub-types
- Alzheimer disease 3 5 trials
- Alzheimer disease type 1 4 trials
- Alzheimer disease 4 3 trials
- Alzheimer disease 10 1 trial
- Alzheimer disease 11 1 trial
- Alzheimer disease 12 1 trial
- Alzheimer disease 13 1 trial
- Alzheimer disease 14 1 trial
- Alzheimer disease 5 1 trial
- Alzheimer disease 6 1 trial
- Alzheimer disease 7 1 trial
- Alzheimer disease 8 1 trial
- Alzheimer disease without neurofibrillary tangles 1 trial
- Alzheimer disease, familial early-onset, with coexisting amyloid and prion pathology 0 trials
-
Hereditary hemorrhagic telangiectasia 34 trials
5 sub-types
-
Multiple endocrine neoplasia type 1 34 trials
-
Autosomal dominant cerebellar ataxia 11 trials · 33 incl. sub-types
15 sub-types
- Autosomal dominant cerebellar ataxia type I 0 trials · 16 incl. sub-types Sub-types →
- Autosomal dominant cerebellar ataxia type III 0 trials · 9 incl. sub-types Sub-types →
- Autosomal dominant cerebellar ataxia type IV 0 trials · 8 incl. sub-types Sub-types →
- Spinocerebellar ataxia 7 7 trials
- Spinocerebellar ataxia 27B, late-onset 4 trials
- Spinocerebellar ataxia 9 2 trials
- Spinocerebellar ataxia 27A 1 trial
- GRID2-related autosomal dominant spinocerebellar ataxia 0 trials
- Spinocerebellar ataxia 43 0 trials
- Spinocerebellar ataxia 44 0 trials
- Spinocerebellar ataxia 47 0 trials
- Spinocerebellar ataxia 48 0 trials
- Spinocerebellar ataxia 49 0 trials
- Spinocerebellar ataxia 50 0 trials
- Spinocerebellar ataxia 51 0 trials
-
Von Hippel-Lindau disease 27 trials
-
Intellectual disability, autosomal dominant 0 trials · 23 incl. sub-types
29 sub-types
- Autosomal dominant syndromic intellectual disability 0 trials · 15 incl. sub-types Sub-types →
- Autosomal dominant non-syndromic intellectual disability 0 trials · 8 incl. sub-types Sub-types →
- Intellectual disability, autosomal dominant 5 2 trials
- Intellectual developmental disorder, autosomal dominant 64 0 trials
- Intellectual developmental disorder, autosomal dominant 65 0 trials
- Intellectual developmental disorder, autosomal dominant 66 0 trials
- Intellectual developmental disorder, autosomal dominant 67 0 trials
- Intellectual developmental disorder, autosomal dominant 68 0 trials
- Intellectual developmental disorder, autosomal dominant 69 0 trials
- Intellectual developmental disorder, autosomal dominant 70 0 trials
- Intellectual developmental disorder, autosomal dominant 71, with behavioral abnormalities 0 trials
- Intellectual developmental disorder, autosomal dominant 72 0 trials
- Intellectual developmental disorder, autosomal dominant 74 0 trials
- Intellectual developmental disorder, autosomal dominant 75 0 trials
- Intellectual developmental disorder, autosomal dominant 76 0 trials
- Intellectual disability, autosomal dominant 1 0 trials
- Intellectual disability, autosomal dominant 10 0 trials
- Intellectual disability, autosomal dominant 11 0 trials
- Intellectual disability, autosomal dominant 2 0 trials
- Intellectual disability, autosomal dominant 24 0 trials
- Intellectual disability, autosomal dominant 3 0 trials
- Intellectual disability, autosomal dominant 38 0 trials
- Intellectual disability, autosomal dominant 39 0 trials
- Intellectual disability, autosomal dominant 4 0 trials
- Intellectual disability, autosomal dominant 40 0 trials
- Intellectual disability, autosomal dominant 42 0 trials
- Intellectual disability, autosomal dominant 6 0 trials
- Intellectual disability, autosomal dominant 9 0 trials
- Neurodevelopmental disorder with or without hyperkinetic movements and seizures, autosomal dominant 0 trials
-
Marfan syndrome 21 trials
1 sub-type
- Neonatal Marfan syndrome 0 trials
-
Li-Fraumeni syndrome 16 trials
-
NOTCH1-related AOS spectrum disorder 0 trials · 16 incl. sub-types
2 sub-types
- Aortic valve disease 1 16 trials
- Adams-Oliver syndrome 5 0 trials
-
Cowden disease 11 trials
8 sub-types
- Cowden syndrome 1 1 trial
- Cowden syndrome 2 0 trials
- Cowden syndrome 3 0 trials
- Cowden syndrome 4 0 trials
- Cowden syndrome 5 0 trials
- Cowden syndrome 6 0 trials
- Cowden syndrome 7 0 trials
- Sacral hemangiomas multiple congenital abnormalities 0 trials
-
Autosomal dominant hypocalcemia 9 trials · 10 incl. sub-types
2 sub-types
- Autosomal dominant hypocalcemia 1 4 trials
- Autosomal dominant hypocalcemia 2 1 trial
-
Peutz-Jeghers syndrome 9 trials
-
Neurohypophyseal diabetes insipidus 9 trials
-
PTEN hamartoma tumor syndrome 6 trials · 8 incl. sub-types
4 sub-types
-
Costello syndrome 7 trials
-
2 sub-types
-
Loeys-Dietz syndrome 6 trials
6 sub-types
- Loeys-Dietz syndrome 1 0 trials
- Loeys-Dietz syndrome 2 0 trials
- Loeys-Dietz syndrome 4 0 trials
- Loeys-Dietz syndrome 6 0 trials
- Rienhoff syndrome 0 trials
- Aneurysm-osteoarthritis syndrome 0 trials
-
Autosomal dominant optic atrophy 6 trials
6 sub-types
- Autosomal dominant optic atrophy, classic form 3 trials
- Al Gazali Khidr Prem Chandran syndrome 0 trials
- Autosomal dominant optic atrophy and peripheral neuropathy 0 trials
- Autosomal dominant optic atrophy plus syndrome 0 trials Sub-types →
- Optic atrophy 3 0 trials
- Optic atrophy 5 0 trials
-
Nevoid basal cell carcinoma syndrome 5 trials
2 sub-types
- Basal cell nevus syndrome 1 0 trials
- Basal cell nevus syndrome 2 0 trials
-
Carney complex 4 trials
3 sub-types
- Carney complex - trismus - pseudocamptodactyly syndrome 0 trials
- Carney complex type 2 0 trials
- Carney complex, type 1 0 trials
-
Multiple endocrine neoplasia type 2A 4 trials
-
Piebaldism 4 trials
-
Muscular dystrophy, limb-girdle, autosomal dominant 0 trials · 4 incl. sub-types
8 sub-types
- Emery-Dreifuss muscular dystrophy 2, autosomal dominant 3 trials
- Autosomal dominant limb-girdle muscular dystrophy type 1D (DNAJB6) 2 trials
- Autosomal dominant limb-girdle muscular dystrophy type 1F 1 trial
- Autosomal dominant limb-girdle muscular dystrophy type 1G 1 trial
- Autosomal dominant limb-girdle muscular dystrophy type 1H 1 trial
- Autosomal dominant limb-girdle muscular dystrophy type 1E (DES) 0 trials
- Muscular dystrophy, limb-girdle, autosomal dominant 4 0 trials
- Myofibrillar myopathy 3 0 trials
-
Muckle-Wells syndrome 3 trials
-
3 sub-types
- LEOPARD syndrome 1 0 trials
- LEOPARD syndrome 2 0 trials
- LEOPARD syndrome 3 0 trials
-
5 sub-types
-
Autosomal dominant Emery-Dreifuss muscular dystrophy 0 trials · 3 incl. sub-types
-
Autosomal dominant intermediate Charcot-Marie-Tooth disease 0 trials · 3 incl. sub-types
8 sub-types
- Charcot-Marie-Tooth disease dominant intermediate D 0 trials · 3 incl. sub-types Sub-types →
- Charcot-Marie-Tooth disease dominant intermediate B 0 trials · 1 incl. sub-types Sub-types →
- Charcot-Marie-Tooth Disease, axonal, type 2GG 0 trials
- Charcot-Marie-Tooth disease dominant intermediate C 0 trials
- Charcot-Marie-Tooth disease dominant intermediate E 0 trials
- Charcot-Marie-Tooth disease dominant intermediate F 0 trials
- Charcot-Marie-Tooth disease, dominant intermediate A 0 trials
- Autosomal dominant intermediate Charcot-Marie-Tooth disease with neuropathic pain 0 trials
-
Birt-Hogg-Dube syndrome 2 trials
2 sub-types
- Birt-Hogg-Dube syndrome 1 0 trials
- Birt-Hogg-Dube syndrome 2 0 trials
-
Muir-Torre syndrome 2 trials
-
Hereditary retinoblastoma 2 trials
-
Multiple endocrine neoplasia type 2B 2 trials
-
Nail-patella syndrome 2 trials
-
Autosomal dominant nonsyndromic hearing loss 1 trial · 2 incl. sub-types
75 sub-types
- Autosomal dominant nonsyndromic hearing loss 9 1 trial
- Autosomal dominant auditory neuropathy 1 0 trials
- Autosomal dominant nonsyndromic hearing loss 1 0 trials
- Autosomal dominant nonsyndromic hearing loss 10 0 trials
- Autosomal dominant nonsyndromic hearing loss 11 0 trials
- Autosomal dominant nonsyndromic hearing loss 12 0 trials
- Autosomal dominant nonsyndromic hearing loss 13 0 trials
- Autosomal dominant nonsyndromic hearing loss 15 0 trials
- Autosomal dominant nonsyndromic hearing loss 16 0 trials
- Autosomal dominant nonsyndromic hearing loss 17 0 trials
- Autosomal dominant nonsyndromic hearing loss 18 0 trials
- Autosomal dominant nonsyndromic hearing loss 20 0 trials
- Autosomal dominant nonsyndromic hearing loss 21 0 trials
- Autosomal dominant nonsyndromic hearing loss 22 0 trials
- Autosomal dominant nonsyndromic hearing loss 23 0 trials
- Autosomal dominant nonsyndromic hearing loss 24 0 trials
- Autosomal dominant nonsyndromic hearing loss 25 0 trials
- Autosomal dominant nonsyndromic hearing loss 27 0 trials
- Autosomal dominant nonsyndromic hearing loss 28 0 trials
- Autosomal dominant nonsyndromic hearing loss 2A 0 trials
- Autosomal dominant nonsyndromic hearing loss 2B 0 trials
- Autosomal dominant nonsyndromic hearing loss 30 0 trials
- Autosomal dominant nonsyndromic hearing loss 31 0 trials
- Autosomal dominant nonsyndromic hearing loss 33 0 trials
- Autosomal dominant nonsyndromic hearing loss 36 0 trials
- Autosomal dominant nonsyndromic hearing loss 3A 0 trials
- Autosomal dominant nonsyndromic hearing loss 3B 0 trials
- Autosomal dominant nonsyndromic hearing loss 40 0 trials
- Autosomal dominant nonsyndromic hearing loss 41 0 trials
- Autosomal dominant nonsyndromic hearing loss 43 0 trials
- Autosomal dominant nonsyndromic hearing loss 44 0 trials
- Autosomal dominant nonsyndromic hearing loss 47 0 trials
- Autosomal dominant nonsyndromic hearing loss 48 0 trials
- Autosomal dominant nonsyndromic hearing loss 49 0 trials
- Autosomal dominant nonsyndromic hearing loss 4A 0 trials
- Autosomal dominant nonsyndromic hearing loss 4B 0 trials
- Autosomal dominant nonsyndromic hearing loss 5 0 trials
- Autosomal dominant nonsyndromic hearing loss 50 0 trials
- Autosomal dominant nonsyndromic hearing loss 51 0 trials
- Autosomal dominant nonsyndromic hearing loss 53 0 trials
- Autosomal dominant nonsyndromic hearing loss 54 0 trials
- Autosomal dominant nonsyndromic hearing loss 56 0 trials
- Autosomal dominant nonsyndromic hearing loss 58 0 trials
- Autosomal dominant nonsyndromic hearing loss 59 0 trials
- Autosomal dominant nonsyndromic hearing loss 6 0 trials
- Autosomal dominant nonsyndromic hearing loss 64 0 trials
- Autosomal dominant nonsyndromic hearing loss 65 0 trials
- Autosomal dominant nonsyndromic hearing loss 66 0 trials
- Autosomal dominant nonsyndromic hearing loss 67 0 trials
- Autosomal dominant nonsyndromic hearing loss 68 0 trials
- Autosomal dominant nonsyndromic hearing loss 69 0 trials
- Autosomal dominant nonsyndromic hearing loss 7 0 trials
- Autosomal dominant nonsyndromic hearing loss 70 0 trials
- Hearing loss, autosomal dominant 34, with or without inflammation 0 trials
- Hearing loss, autosomal dominant 37 0 trials
- Hearing loss, autosomal dominant 71 0 trials
- Hearing loss, autosomal dominant 72 0 trials
- Hearing loss, autosomal dominant 73 0 trials
- Hearing loss, autosomal dominant 74 0 trials
- Hearing loss, autosomal dominant 75 0 trials
- Hearing loss, autosomal dominant 76 0 trials
- Hearing loss, autosomal dominant 77 0 trials
- Hearing loss, autosomal dominant 78 0 trials
- Hearing loss, autosomal dominant 79 0 trials
- Hearing loss, autosomal dominant 80 0 trials
- Hearing loss, autosomal dominant 81 0 trials
- Hearing loss, autosomal dominant 82 0 trials
- Hearing loss, autosomal dominant 83 0 trials
- Hearing loss, autosomal dominant 84 0 trials
- Hearing loss, autosomal dominant 85 0 trials
- Hearing loss, autosomal dominant 86 0 trials
- Hearing loss, autosomal dominant 87 0 trials
- Hearing loss, autosomal dominant 88 0 trials
- Hearing loss, autosomal dominant 89 0 trials
- Hearing loss, autosomal dominant 90 0 trials
-
Autosomal dominant progressive external ophthalmoplegia 1 trial · 2 incl. sub-types
5 sub-types
- Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal dominant 2 1 trial
- Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal dominant 1 0 trials
- Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal dominant 3 0 trials
- Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal dominant 4 0 trials
- Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal dominant 5 0 trials
-
Brooke-Spiegler syndrome 0 trials · 2 incl. sub-types
2 sub-types
- Familial cylindromatosis 2 trials
- Familial multiple trichoepithelioma 0 trials Sub-types →
-
Denys-Drash syndrome 1 trial
-
Duane-radial ray syndrome 1 trial
2 sub-types
-
EEC syndrome 1 trial
-
Timothy syndrome 1 trial
2 sub-types
- Timothy syndrome, classic type 0 trials · 1 incl. sub-types Sub-types →
- Timothy syndrome, atypical type 0 trials
-
Waardenburg syndrome 1 trial
5 sub-types
- Waardenburg syndrome type 1 1 trial
- Waardenburg syndrome type 2 1 trial Sub-types →
- Waardenburg syndrome type 3 0 trials
- Waardenburg syndrome, IIa 2F 0 trials
- Waardenburg-Shah syndrome 0 trials Sub-types →
-
Cherubism 1 trial
1 sub-type
-
Macrocephaly-autism syndrome 1 trial
-
Proximal symphalangism 1 trial
2 sub-types
- Proximal symphalangism 1A 0 trials
- Symphalangism, proximal, 1B 0 trials
-
ADULT syndrome 0 trials
-
1 sub-type
- Mild hypophosphatasia 0 trials
-
Birk-Barel syndrome 0 trials
-
Coffin-Siris syndrome 1 0 trials
-
Delpire-McNeill syndrome 0 trials
-
Ehlers-Danlos syndrome, classic type 0 trials
2 sub-types
-
4 sub-types
- Boomerang dysplasia 0 trials
- Larsen syndrome 0 trials
- Atelosteogenesis type I 0 trials
- Atelosteogenesis type III 0 trials
-
Feingold syndrome 0 trials
2 sub-types
- Feingold syndrome type 1 0 trials
- Feingold syndrome type 2 0 trials
-
Flynn-Aird syndrome 0 trials
-
Frasier syndrome 0 trials
-
GUCY2D-related dominant retinopathy 0 trials
1 sub-type
-
Holt-Oram syndrome 0 trials
1 sub-type
- Heart-hand syndrome type 3 0 trials
-
Houge-Janssens syndrome 2 0 trials
-
IMPG1-related dominant retinopathy 0 trials
1 sub-type
-
KINSSHIP syndrome 0 trials
-
LADD syndrome 0 trials
3 sub-types
- LADD syndrome 1 0 trials
- Lacrimoauriculodentodigital syndrome 2 0 trials
- Lacrimoauriculodentodigital syndrome 3 0 trials
-
LAMA5-related multisystemic syndrome 0 trials
-
MAX-related tumor predisposition 0 trials
-
5 sub-types
- Brachydactyly type B2 0 trials
- Multiple synostoses syndrome 1 0 trials
- Proximal symphalangism 1A 0 trials
- Stapes ankylosis with broad thumbs and toes 0 trials
- Tarsal-carpal coalition syndrome 0 trials
-
PCWH syndrome 0 trials
-
PROM1-related dominant retinopathy 0 trials
2 sub-types
- Stargardt disease 4 0 trials
- Retinal macular dystrophy type 2 0 trials
-
Pelger-Huet anomaly 0 trials
-
Pilarowski-Bjornsson syndrome 0 trials
-
RP1-related dominant retinopathy 0 trials
-
RPE65-related dominant retinopathy 0 trials
1 sub-type
-
Rapp-Hodgkin syndrome 0 trials
-
TMEM127-related tumor predisposition 0 trials
-
Townes-Brocks syndrome 0 trials
2 sub-types
- Townes-Brocks syndrome 1 0 trials
- Townes-Brocks syndrome 2 0 trials
-
Treacher-Collins syndrome 0 trials
4 sub-types
- Treacher Collins syndrome 1 0 trials
- Treacher Collins syndrome 2 0 trials
- Treacher Collins syndrome 3 0 trials
- Treacher Collins syndrome 4 0 trials
-
Acroosteolysis dominant type 0 trials
-
Amelogenesis imperfecta type 1B 0 trials
-
Arthrogryposis, distal, type 2B2 0 trials
-
Arthrogryposis, distal, type 2B3 0 trials
-
Autosomal dominant Aarskog syndrome 0 trials
-
Autosomal dominant Alport syndrome 0 trials
-
Autosomal dominant Robinow syndrome 0 trials
3 sub-types
- Autosomal dominant Robinow syndrome 1 0 trials
- Autosomal dominant Robinow syndrome 2 0 trials
- Autosomal dominant Robinow syndrome 3 0 trials
-
Autosomal dominant brachyolmia 0 trials
-
Autosomal dominant cataract 0 trials
1 sub-type
-
2 sub-types
-
13 sub-types
- Autosomal dominant spastic paraplegia type 9 0 trials Sub-types →
- Hereditary spastic paraplegia 17 0 trials
- Hereditary spastic paraplegia 29 0 trials
- Hereditary spastic paraplegia 36 0 trials
- Hereditary spastic paraplegia 38 0 trials
- Spastic paraplegia 18a, autosomal dominant 0 trials
- Spastic paraplegia, intellectual disability, nystagmus, and obesity 0 trials
- Spastic paraplegia-Paget disease of bone syndrome 0 trials
- Spastic paraplegia-epilepsy-intellectual disability syndrome 0 trials
- Spastic paraplegia-facial-cutaneous lesions syndrome 0 trials
- Spastic paraplegia-nephritis-deafness syndrome 0 trials
- Spastic paraplegia-neuropathy-poikiloderma syndrome 0 trials
- Spastic paraplegia-precocious puberty syndrome 0 trials
-
Autosomal dominant cutis laxa 0 trials
3 sub-types
- Cutis laxa, autosomal dominant 1 0 trials
- Cutis laxa, autosomal dominant 2 0 trials
- Cutis laxa, autosomal dominant 3 0 trials
-
Autosomal dominant distal myopathy 0 trials
15 sub-types
- Finnish upper limb-onset distal myopathy 0 trials
- KLHL9-related early-onset distal myopathy 0 trials
- TARDBP-related predominantly upper-limb distal myopathy 0 trials
- Adult-onset distal myopathy due to VCP mutation 0 trials
- Asymetric thumb-handgrip weakness-distal myopathy 0 trials
- Calf-predominant weakness-gastrocnemius medialis atrophy-distal myopathy 0 trials
- Distal myopathy with posterior leg and anterior hand involvement 0 trials
- Distal myopathy with vocal cord weakness 0 trials
- Distal myopathy, Tateyama type 0 trials
- Distal myopathy, Welander type 0 trials
- Myofibrillar myopathy 2 0 trials
- Myofibrillar myopathy 3 0 trials
- Myofibrillar myopathy 4 0 trials
- Myopathy, myofibrillar, 9, with early respiratory failure 0 trials
- Tibial muscular dystrophy 0 trials
-
2 sub-types
-
2 sub-types
- Mild ichthyosis vulgaris 0 trials
- Severe ichthyosis vulgaris 0 trials
-
Autosomal dominant keratitis 0 trials
-
Autosomal dominant myoglobinuria 0 trials
-
Autosomal dominant omodysplasia 0 trials
-
Autosomal dominant osteopetrosis 0 trials
4 sub-types
- Autosomal dominant osteopetrosis 1 0 trials
- Autosomal dominant osteopetrosis 2 0 trials
- Osteopetrosis, autosomal dominant 3 0 trials
- Osteopetrosis, autosomal dominant 4 0 trials
-
3 sub-types
-
3 sub-types
-
Autosomal dominant spastic ataxia 0 trials
3 sub-types
- Spastic ataxia 1 0 trials
- Spastic ataxia 11, autosomal dominant 0 trials
- Spastic ataxia 7 0 trials
-
Autosomal dominant titinopathy 0 trials
4 sub-types
- Dilated cardiomyopathy 1G 0 trials
- Hypertrophic cardiomyopathy 9 0 trials
- Myopathy, myofibrillar, 9, with early respiratory failure 0 trials
- Tibial muscular dystrophy 0 trials
-
Blepharocheilodontic syndrome 0 trials
3 sub-types
- Martinez Monasterio Pinheiro syndrome 0 trials
- Blepharocheilodontic syndrome 1 0 trials
- Blepharocheilodontic syndrome 2 0 trials
-
5 sub-types
- Blepharophimosis-epicanthus inversus-ptosis due to 3q23 rearrangement syndrome 0 trials
- Blepharophimosis-epicanthus inversus-ptosis due to a point mutation syndrome 0 trials
- Blepharophimosis-epicanthus inversus-ptosis due to copy number variations 0 trials
- Blepharophimosis-ptosis-epicanthus inversus syndrome type 1 0 trials
- Blepharophimosis-ptosis-epicanthus inversus syndrome type 2 0 trials
-
Branchio-oto-renal syndrome 0 trials
2 sub-types
- Branchiootorenal syndrome 1 0 trials
- Branchiootorenal syndrome 2 0 trials
-
Branchiooculofacial syndrome 0 trials
-
Calcaneonavicular coalition 0 trials
-
Distal arthrogryposis type 2B1 0 trials
-
Familial antiphospholipid syndrome 0 trials
-
Hand-foot-genital syndrome 0 trials
-
Heart-hand syndrome, Slovenian type 0 trials
-
Isolated congenital adermatoglyphia 0 trials
-
Monilethrix 0 trials
3 sub-types
- Monilethrix-1 0 trials
- Monilethrix-2 0 trials
- Monilethrix-3 0 trials
-
Multiple endocrine neoplasia type 4 0 trials
-
11 sub-types
- Distal hereditary motor neuropathy type 2 0 trials Sub-types →
- Distal hereditary motor neuropathy type 7 0 trials Sub-types →
- Hereditary spastic paraplegia 17 0 trials
- Myopathy, myofibrillar, 13, with rimmed vacuoles 0 trials
- Neuronopathy, distal hereditary motor, autosomal dominant 1 0 trials
- Neuronopathy, distal hereditary motor, autosomal dominant 10 0 trials
- Neuronopathy, distal hereditary motor, autosomal dominant 11 0 trials
- Neuronopathy, distal hereditary motor, autosomal dominant 15 0 trials
- Neuronopathy, distal hereditary motor, autosomal dominant 8 0 trials
- Neuronopathy, distal hereditary motor, type 5 0 trials Sub-types →
- Neuronopathy, distal hereditary motor, type 9 0 trials
-
Renal coloboma syndrome 0 trials
-
Retinoschisis, autosomal dominant 0 trials
-
Thanatophoric dysplasia type 1 0 trials
Most studied deeper sub-types
-
Cancer drug tested against deadly infant heart disease
Disease control Not yet recruitingResearchers are testing whether trametinib, an FDA-approved cancer drug, can help infants with RASopathies who have a severe, life-threatening heart condition called hypertrophic cardiomyopathy. The trial enrolls about 25 babies with a confirmed genetic diagnosis. Participants re…
Phase 3 • Sponsor: Carelon Research • Aim: Disease control
Last updated Sep 16, 2026 00:00 UTC
-
Could a daily pill tame rare cancers in teens? new trial investigates
Disease control Not yet recruitingThis phase 2 trial tests the safety of belzutifan, a daily oral tablet, in adolescents with rare solid tumors that cannot be surgically removed or have spread. The study includes three tumor types: pheochromocytoma/paraganglioma (PPGL), wild-type gastrointestinal stromal tumors (…
Phase 2 • Sponsor: Merck Sharp & Dohme LLC • Aim: Disease control
Last updated Sep 13, 2026 00:00 UTC
-
Can targeted brain zaps ease movement problems in a rare ataxia?
Disease control Not yet recruitingThis trial tests a non-invasive brain stimulation technique called transcranial temporal interference stimulation (tTIS) in people with spinocerebellar ataxia type 3, a genetic condition that affects coordination and balance. The stimulation targets a deep brain region involved i…
Sponsor: First Affiliated Hospital of Fujian Medical University • Aim: Disease control
Last updated Sep 03, 2026 00:00 UTC
-
Immune cells tailored to attack lung cancer show promise in early trial
Disease control Not yet recruitingThis trial investigates whether specially engineered T cells can safely target and fight lung cancer. Participants have advanced or relapsed lung cancer and receive a single infusion of their own T cells that have been trained to recognize cancer-specific markers. The study aims …
Phase 1/2 • Sponsor: Shenzhen Geno-Immune Medical Institute • Aim: Disease control
Last updated Aug 28, 2026 00:00 UTC
-
Can brain stimulation tame ataxia?
Disease control Not yet recruitingThis trial tests whether deep brain stimulation (DBS) targeting the cerebellum is safe and feasible for people with spinocerebellar ataxia types 1 and 3, a group of inherited disorders that cause progressive problems with movement and coordination. The study will enroll 12 adults…
Sponsor: Gordon H. Baltuch • Aim: Disease control
Last updated Aug 09, 2026 00:00 UTC
-
Blood test may let cancer patients take safe breaks from immunotherapy
Disease control Not yet recruitingThis trial investigates whether a sensitive blood test (Signatera) can detect when it is safe to pause immunotherapy in people with advanced solid tumors like lung cancer, melanoma, and colorectal cancer. Participants are randomly assigned to either continuous standard immunother…
Sponsor: Natera, Inc. • Aim: Disease control
Last updated Aug 06, 2026 00:00 UTC
-
Can a Two-Drug combo stop a rare, aggressive nerve tumor?
Disease control Not yet recruitingThis phase 2 trial is testing whether the combination of avutometinib and defactinib can stop or shrink malignant peripheral nerve sheath tumors (MPNST) that have returned or cannot be removed with surgery. The study enrolls people over 12 years old with relapsed, refractory, met…
Phase 2 • Sponsor: Girish Dhall, MD • Aim: Disease control
Last updated Aug 06, 2026 00:00 UTC
-
Purple potatoes put to the test: a Heart-Healthy superfood in the making?
Disease control Not yet recruitingThis trial investigates whether eating purple-fleshed potatoes daily for four weeks can improve blood pressure and other heart health markers in men with prehypertension. Participants will consume either purple or white potato puree in a crossover design, with measurements taken …
Sponsor: Instituto de Investigacion Nutricional, Peru • Aim: Disease control
Last updated Jul 31, 2026 00:00 UTC
-
Can a gentle electric field fix a racing heart?
Disease control Not yet recruitingThis trial tests whether a procedure called pulsed field ablation can safely treat ventricular arrhythmias—abnormal heart rhythms that can be life-threatening. About 30 people with frequent premature heartbeats or ventricular tachycardia will receive the treatment using a special…
Sponsor: Xi'an Jiaotong University • Aim: Disease control
Last updated Jul 29, 2026 00:00 UTC
-
Could a common cholesterol pill be the key to slowing a deadly kidney disease?
Disease control Not yet recruitingThis study tests whether bempedoic acid, a drug already approved for high cholesterol, can safely slow the progression of autosomal dominant polycystic kidney disease (ADPKD). About 120 adults with rapidly progressing ADPKD will receive either the drug or a placebo for two years.…
Phase 2 • Sponsor: Kenneth Hallows • Aim: Disease control
Last updated Jul 25, 2026 00:00 UTC
-
New platform trial takes on NF2 tumors with multiple drug strategies
Disease control Not yet recruitingThis trial tests several drugs in people with NF2-related schwannomatosis, a condition that causes tumors on nerves and in the brain. The study uses a flexible 'platform' design to evaluate treatments for four tumor types: vestibular schwannomas, non-vestibular schwannomas, menin…
Phase 2 • Sponsor: Beijing Tiantan Hospital • Aim: Disease control
Last updated Jul 22, 2026 00:00 UTC
-
Could a cancer drug shrink brain tumors and save hearing in a rare nerve disorder?
Disease control Not yet recruitingThis trial tests the drug selumetinib in people with NF2-related schwannomatosis, a genetic condition that causes non-cancerous tumors on nerves, often leading to hearing loss. The study includes both adults and children whose tumors cannot be surgically removed or are growing. R…
Phase 2 • Sponsor: Beijing Tiantan Hospital • Aim: Disease control
Last updated Jul 18, 2026 00:00 UTC
-
Drug combo aims to shrink NF2 tumors and save hearing
Disease control Not yet recruitingThis trial tests whether combining two drugs—luvometinib (a targeted therapy) and serplulimab (an immunotherapy)—can shrink tumors and improve hearing in people with NF2-related schwannomatosis. Participants have progressive vestibular schwannomas or meningiomas that are not suit…
Phase 1/2 • Sponsor: Beijing Tiantan Hospital • Aim: Disease control
Last updated Jul 18, 2026 00:00 UTC
-
Could a sublingual tablet repair the Brain's leaky barrier in CADASIL?
Disease control Not yet recruitingThis trial investigates whether edaravone dexborneol sublingual tablets can improve blood-brain barrier function in people with CADASIL, a genetic condition that causes small strokes and cognitive decline. About 60 adults aged 18 to 80 with confirmed CADASIL will be observed for …
Phase 2 • Sponsor: Huashan Hospital • Aim: Disease control
Last updated Jul 11, 2026 00:00 UTC
-
New daily pill aims to tame stubborn seizures in tuberous sclerosis
Disease control Not yet recruitingThis study tests an oral drug, AV078, in people aged 12 and older with tuberous sclerosis complex (TSC) whose seizures are not controlled by standard medications. Participants are randomly assigned to receive AV078 or a placebo for 12 weeks. The goal is to see if AV078 safely red…
Phase 2 • Sponsor: Aeovian Pharmaceuticals, Inc. • Aim: Disease control
Last updated Jul 04, 2026 00:00 UTC
-
Can a Low-Carb diet calm kidney disease inflammation?
Disease control Not yet recruitingThis study tests whether a low-carbohydrate, plant-based diet can lower inflammation in people with autosomal dominant polycystic kidney disease (ADPKD). Thirty-six adults will try the special diet and their usual diet in random order, each for 12 weeks. The main goal is to see i…
Sponsor: Assaf-Harofeh Medical Center • Aim: Disease control
Last updated Jun 28, 2026 00:00 UTC
-
New study could change how Men's UTIs are treated
Disease control Not yet recruitingThis study tests whether a common antibiotic for women's UTIs, fosfomycin-trometamol, works well for men with urinary tract infections. Current treatments can have serious side effects and increase antibiotic resistance. The trial will enroll 138 men in primary care and monitor f…
Phase 3 • Sponsor: University Hospital, Rouen • Aim: Disease control
Last updated Jun 27, 2026 13:07 UTC
-
Could a cancer drug boost social abilities in rare genetic condition?
Disease control Not yet recruitingThis study tests whether everolimus, a drug already approved for other conditions, can safely improve social abilities in people with PTEN Hamartoma Tumor Syndrome (PHTS). About 60 adults and children with PHTS and social difficulties will take either everolimus or a placebo for …
Phase 2/3 • Sponsor: Boston Children's Hospital • Aim: Disease control
Last updated Jun 27, 2026 13:03 UTC
-
Smart patches could save hearts: hospital trial tests continuous monitoring
Disease control Not yet recruitingThis study tests whether a wearable monitoring system (ECG patch, temperature patch, and pulse oximeter) can reduce major heart complications in hospitalized patients with heart disease. About 1500 adults will be monitored either with standard care (vital signs every 4-8 hours) o…
Sponsor: Yonsei University • Aim: Disease control
Last updated Jun 27, 2026 13:01 UTC
-
Glowing goggles could prevent calcium crash after thyroid surgery
Disease control Not yet recruitingThis study tests whether a wearable goggle system that makes parathyroid glands glow can help surgeons find and protect them during thyroid removal. About 280 adults having thyroid surgery will take part. The goal is to reduce the risk of low calcium levels after surgery, a commo…
Sponsor: Ss. Cyril and Methodius University of Skopje • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
First human trial of TS1-ASO aims to tame rare genetic brain disorder
Disease control Not yet recruitingThis first-in-human trial tests a genetic drug called TS1-ASO in 5 children with Timothy Syndrome, a rare condition causing severe heart and brain problems. The drug is injected into the spine to target the genetic root of the disease. The main goal is to check safety and how the…
Phase 1/2 • Sponsor: Stanford University • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
Sound waves may help clear Alzheimer's brain clogs
Disease control Not yet recruitingThis early-stage study tests whether a focused ultrasound can safely and temporarily open the brain's protective barrier in people with early Alzheimer's disease. The goal is to see if this helps clear harmful amyloid and tau proteins that build up in the brain. Six participants …
Phase 1 • Sponsor: Columbia University • Aim: Disease control
Last updated Jun 27, 2026 12:34 UTC
-
New registry to monitor Belzutifan's Real-World impact on rare VHL tumors
Disease control Not yet recruitingThis study will follow 100 adults with von Hippel-Lindau (VHL) disease who choose to take belzutifan. Researchers will track how well the drug shrinks tumors, its side effects, and its impact on quality of life and healthcare costs. The goal is to better understand the drug's rea…
Sponsor: Chinese University of Hong Kong • Aim: Disease control
Last updated Jun 27, 2026 12:29 UTC
-
Could Low-Dose radiation slow Alzheimer's? new trial aims to find out
Disease control Not yet recruitingThis study tests whether low-dose radiation to the whole brain can slow down Alzheimer's disease in people with early-onset symptoms. Fifty participants will be randomly assigned to receive either the radiation treatment or a sham procedure. Researchers will track changes in memo…
Sponsor: Heinrich-Heine University, Duesseldorf • Aim: Disease control
Last updated Jun 27, 2026 12:29 UTC
-
Could stem cells help people with spinocerebellar ataxia? new trial aims to find out
Disease control Not yet recruitingThis Phase 2 trial tests whether umbilical cord stem cells can safely improve movement and coordination in people with spinocerebellar ataxia (types 1, 2, 3, and 6). Forty-five participants will receive the cells through an IV and a spinal injection. The main goal is to see if sy…
Phase 2 • Sponsor: Sclnow Biotechnology Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
New drug combo aims to tackle tough brain tumors in NF1 patients
Disease control Not yet recruitingThis phase 2 trial tests the drug mirdametinib, alone or with radiation, in people with NF1-related high-grade gliomas (aggressive brain tumors). It includes three groups: those with recurrent sporadic glioblastoma, newly diagnosed NF1-associated glioblastoma, and other NF1-relat…
Phase 2 • Sponsor: University of Alabama at Birmingham • Aim: Disease control
Last updated Jun 27, 2026 12:06 UTC
-
Can a cholesterol drug stop a heart valve from hardening?
Disease control Not yet recruitingThis study tests whether a drug called a PCSK9 inhibitor (Tafolecimab) can slow the progression of mild to moderate calcific aortic stenosis, a condition where the heart valve narrows and hardens. Researchers will give the drug to half of 160 participants and compare changes in v…
Phase 3 • Sponsor: Beijing Anzhen Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:04 UTC
-
Could a High-Fat diet prevent aortic surgery in marfan patients?
Disease control Not yet recruitingThis pilot study tests whether a carefully supervised ketogenic diet can help people with Marfan syndrome who have a chronic aortic dissection avoid surgery for one year. Fifteen adults aged 18-50 will follow the diet with guidance from a dietitian, measure their blood ketones at…
Sponsor: Washington University School of Medicine • Aim: Disease control
Last updated Jun 27, 2026 12:01 UTC
-
One-Patient trial aims to treat Ultra-Rare genetic disorder
Disease control Not yet recruitingThis study tests a custom-made drug called an antisense oligonucleotide (ASO) designed for one person with Schuurs-Hoeijmakers syndrome, a rare genetic condition. The drug aims to correct a specific genetic mutation to improve communication and motor skills. Only one participant …
Phase 1/2 • Sponsor: n-Lorem Foundation • Aim: Disease control
Last updated Jun 27, 2026 11:01 UTC
-
Could stem cells help people with spinocerebellar ataxia?
Disease control Not yet recruitingThis early-stage trial tests whether stem cells and their exosomes (tiny particles that help cells communicate) can safely improve movement in people with spinocerebellar ataxia, a condition that affects coordination and balance. Ninety participants will receive the treatment thr…
Phase 1/2 • Sponsor: Biocells Medical • Aim: Disease control
Last updated Jun 27, 2026 11:01 UTC
-
Could immunotherapy spare some colon cancer patients from surgery?
Disease control Not yet recruitingThis study tests giving an immunotherapy drug (pembrolizumab) before surgery to people with a specific type of colon cancer (dMMR). The goal is to see if the drug can shrink or eliminate the tumor so some patients may avoid surgery and instead be closely monitored. About 152 adul…
Phase 2 • Sponsor: Ismail Gögenur • Aim: Disease control
Last updated Jun 27, 2026 09:06 UTC
-
Dietary intervention aims to slow kidney cyst progression
Disease control Not yet recruitingThis study tests whether a 12-month diet low in salt, caffeine, protein, and carbs, but high in potassium and water, can slow kidney cyst growth in 30 adults with ADPKD. Participants are split into diet and regular diet groups. The goal is to see if the diet reduces cyst progress…
Sponsor: Loma Linda University • Aim: Disease control
Last updated Jun 27, 2026 09:00 UTC
-
New pill aims to shrink tumors in rare nerve disorder
Disease control Not yet recruitingThis early-phase trial tests an oral drug called Trineumin (PRG-N-01) in 25 adults with neurofibromatosis type II (NF2), a genetic condition that causes non-cancerous tumors on nerves. The study has two parts: first finding a safe dose, then checking if that dose can shrink tumor…
Phase 1/2 • Sponsor: PRG Science & Technology Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 08:13 UTC
-
Can a simple blood test spot ovarian cancer before it starts?
Diagnosis Not yet recruitingThis study is looking at whether a blood test called Galleri can help detect ovarian cancer early in people with BRCA1 or BRCA2 gene changes, who are at higher risk. Participants will give a blood sample and answer questionnaires about their experience. The study will also check …
Sponsor: Weill Medical College of Cornell University • Aim: Diagnosis
Last updated Sep 13, 2026 00:00 UTC
-
Liquid biopsies may let lynch syndrome patients skip half their colonoscopies
Diagnosis Not yet recruitingThis study tests whether annual liquid biopsies (from blood, urine, stool, and vaginal swabs) can safely replace colonoscopies every 18 months for people with Lynch syndrome. 2,000 participants will be split into two groups: one gets standard care (colonoscopy every 18 months), t…
Sponsor: UNICANCER • Aim: Diagnosis
Last updated Aug 05, 2026 00:00 UTC
-
Could a pill camera replace the colonoscopy for lynch syndrome patients?
Diagnosis Not yet recruitingThis study tests whether a swallowable capsule camera (colon capsule endoscopy) can effectively screen for colorectal cancer in people with Lynch syndrome, a genetic condition that greatly increases cancer risk. Researchers will compare the capsule's ability to find polyps and ot…
Sponsor: Region Skane • Aim: Diagnosis
Last updated Jun 27, 2026 12:25 UTC
-
AI-Powered 1-Minute ECG could spot hidden heart risks
Diagnosis Not yet recruitingThis study will enroll 5000 adults to see if a one-minute, single-lead ECG, analyzed by machine learning, can detect heart conditions like high blood pressure, heart failure, and diabetes. Participants will have their ECG recorded twice and compared with full medical exams. The g…
Sponsor: I.M. Sechenov First Moscow State Medical University • Aim: Diagnosis
Last updated Jun 27, 2026 12:08 UTC
-
Saliva test may unlock genetic secrets missed by blood tests
Diagnosis Not yet recruitingThis study tests whether a simple saliva swab can find genetic causes of neurodevelopmental or intellectual disorders when standard blood tests have not. Researchers will use advanced DNA sequencing on cheek cells from 50 participants. The goal is to improve diagnosis and help gu…
Sponsor: Centre Hospitalier Universitaire de Besancon • Aim: Diagnosis
Last updated Jun 27, 2026 12:07 UTC
-
New DNA sequencer could make genetic testing cheaper and faster
Diagnosis Not yet recruitingThis study compares a new DNA sequencing platform (MGI) against the current standard (Illumina) for diagnosing hereditary cancers like breast and ovarian cancer, Lynch syndrome, and intestinal polyposis. Researchers will analyze 248 patient samples using both platforms to see if …
Sponsor: Fondazione Policlinico Universitario Agostino Gemelli IRCCS • Aim: Diagnosis
Last updated Jun 26, 2026 14:56 UTC
-
Could a vaccine stop cancer before it starts in lynch syndrome?
Prevention Not yet recruitingThis early-phase trial tests a personalized vaccine made from a person's own immune cells (dendritic cells) loaded with cancer-specific markers. The goal is to train the immune system to recognize and destroy precancerous cells in people with Lynch syndrome, who have a high risk …
Phase 1/2 • Sponsor: Radboud University Medical Center • Aim: Prevention
Last updated Aug 21, 2026 00:00 UTC
-
Personalized vaccine aims to stop lynch syndrome cancers before they start
Prevention Not yet recruitingThis phase III trial tests whether a vaccine made from a person's own immune cells can prevent cancer in 372 adults with Lynch syndrome, a genetic condition that raises cancer risk. Participants receive either the vaccine or a placebo and are monitored for tumor development. The …
Phase 3 • Sponsor: Radboud University Medical Center • Aim: Prevention
Last updated Jun 27, 2026 12:37 UTC
-
New ointment could tame HHT nosebleeds
Symptom relief Not yet recruitingThis early-phase trial tests a new nasal ointment called TOR-582, which contains sirolimus, in 27 adults with hereditary hemorrhagic telangiectasia (HHT) who have frequent nosebleeds. Participants apply the ointment inside their nostrils twice daily for 12 weeks, with different s…
Phase 1 • Sponsor: Columbia University • Aim: Symptom relief
Last updated Aug 23, 2026 00:00 UTC
-
Thinking through tasks: a new therapy aims to help kids with intellectual disability master daily life
Symptom relief Not yet recruitingThis pilot study tests a therapy protocol based on cognitive-occupational principles (CO-OP) for children and adolescents aged 10-21 with mild to moderate intellectual disability. The intervention involves weekly 45-minute sessions over 12-15 weeks, delivered by occupational ther…
Sponsor: Miri Tal-Saban • Aim: Symptom relief
Last updated Aug 13, 2026 00:00 UTC
-
Rewiring the brain to silence chronic pain — a bold psychological therapy is put to the test
Symptom relief Not yet recruitingThis trial tests whether pain reprocessing therapy (PRT) — a brief psychological treatment that combines education, cognitive restructuring, and body-focused techniques — can reduce chronic pain. Adults with persistent pain lasting over three months are randomly assigned to full …
Sponsor: Ben-Gurion University of the Negev • Aim: Symptom relief
Last updated Jul 26, 2026 00:00 UTC
-
Vibrating needles could ease back pain without extra risk
Symptom relief Not yet recruitingThis study looks at whether adding a gentle vibration to dry needling can reduce low back pain better than dry needling alone. About 36 adults with long-term low back pain will receive either standard dry needling or dry needling with vibration. The goal is to see if the vibratio…
Sponsor: Universidad de Zaragoza • Aim: Symptom relief
Last updated Jul 15, 2026 00:00 UTC
-
Robot-Assisted mastectomy: could it mean less pain and faster healing?
Symptom relief Not yet recruitingThis study compares two types of nipple-sparing mastectomy: one done with a robotic arm through a small side incision, and the standard open surgery. Researchers want to see if the robotic method improves women's satisfaction, body image, and recovery over 12 months. The trial wi…
Sponsor: Beaumont Hospital • Aim: Symptom relief
Last updated Jun 27, 2026 07:58 UTC
-
Could you help scientists unlock genetic cancer secrets?
Knowledge-focused Not yet recruitingThis study screens up to 1,000 people with personal or family histories of certain cancers to see if they qualify for ongoing genetics research at the National Cancer Institute. Participants fill out a 15-20 minute online survey about their health and family history. No treatment…
Sponsor: National Cancer Institute (NCI) • Aim: Knowledge-focused
Last updated Sep 21, 2026 15:00 UTC
-
Why do some children arrive at the ER with a racing or skipping heart?
Knowledge-focused Not yet recruitingResearchers at Assiut University Children Hospital are studying how often children who come to the emergency department have an abnormal heart rhythm. The study includes children aged 1 month to 18 years who arrive with symptoms such as palpitations, chest pain, fainting, or trou…
Sponsor: Assiut University • Aim: Knowledge-focused
Last updated Sep 19, 2026 00:00 UTC
-
Patients and staff team up to redesign hospital clinics for sensory needs
Knowledge-focused Not yet recruitingThis project at King's College London asks how hospital outpatient departments can work better for people with neurofibromatosis who also have sensory challenges. About 30 patients, carers, and staff from Guy's and St Thomas' NHS Foundation Trust take part in interviews, observat…
Sponsor: King's College London • Aim: Knowledge-focused
Last updated Sep 16, 2026 00:00 UTC
-
A routine calcium reading could reveal how sick a sepsis patient really is
Knowledge-focused Not yet recruitingResearchers at Assiut University are studying whether ionized calcium levels, measured from a routine blood sample when a patient enters the ICU, can signal how severe sepsis or septic shock is. The study follows 160 adults admitted to intensive care within 24 hours of presentati…
Sponsor: Assiut University • Aim: Knowledge-focused
Last updated Sep 12, 2026 00:00 UTC
-
Wearable patches could spot heart danger hiding in cancer treatment
Knowledge-focused Not yet recruitingThis pilot study is testing whether wearable patch monitors can help detect heart problems early in adults undergoing treatment for breast cancer, blood cancers, or multiple myeloma. Participants will wear two patches—one that tracks heart rhythm continuously and another that rec…
Sponsor: University of Minnesota • Aim: Knowledge-focused
Last updated Sep 12, 2026 00:00 UTC
-
Will a kidney disease drug alter birth control?
Knowledge-focused Not yet recruitingThis phase 1 study tests whether VX-407, an experimental drug for polycystic kidney disease, changes how combined oral contraceptives are processed in the body. Healthy women will take VX-407 alongside different birth control pills, and researchers will measure hormone levels in …
Phase 1 • Sponsor: Vertex Pharmaceuticals Incorporated • Aim: Knowledge-focused
Last updated Aug 30, 2026 00:00 UTC
-
New online toolkit aims to boost cancer screening in lynch syndrome families
Knowledge-focused Not yet recruitingThis study tests an online tool called 'Let's Talk' designed to help people with Lynch syndrome encourage their relatives to get screened for the condition. Lynch syndrome is a genetic disorder that raises cancer risk, and only about half of close relatives currently get tested. …
Sponsor: UNC Lineberger Comprehensive Cancer Center • Aim: Knowledge-focused
Last updated Aug 28, 2026 00:00 UTC
-
New program aims to keep High-Risk cancer gene carriers on track with screenings
Knowledge-focused Not yet recruitingThis study tests a program to help people with inherited cancer gene mutations (like BRCA or Lynch syndrome) stick to recommended cancer screening schedules. Researchers will interview 80 female participants and provide standard care to see if this approach improves adherence and…
Sponsor: M.D. Anderson Cancer Center • Aim: Knowledge-focused
Last updated Aug 26, 2026 00:00 UTC
-
New program aims to boost family communication about genetic risks
Knowledge-focused Not yet recruitingThis study tests a program to help people with certain genetic mutations share their results with at-risk relatives and make informed decisions about genetic testing and care. About 2100 adults in the U.S. who speak English or Spanish will take part. The program provides free gen…
Phase 3 • Sponsor: M.D. Anderson Cancer Center • Aim: Knowledge-focused
Last updated Jul 19, 2026 00:00 UTC
-
Scientists track hidden brain tumors in children with rare genetic condition
Knowledge-focused Not yet recruitingThis study looks at children with Von Hippel-Lindau (VHL) disease, a rare genetic condition that causes tumors in the brain and spinal cord. Researchers want to understand how these tumors grow over time and what factors predict when a child will need surgery. By reviewing medica…
Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Knowledge-focused
Last updated Jul 17, 2026 00:00 UTC
-
Thyroid hormones may hold clues to kidney disease progression
Knowledge-focused Not yet recruitingThis observational study will measure thyroid hormone levels in stored blood and urine samples from 51 people with severe chronic kidney disease (stages 4 and 5). Researchers aim to understand how these hormones differ in patients with and without polycystic kidney disease. The s…
Sponsor: Mario Negri Institute for Pharmacological Research • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:03 UTC
-
French biobank aims to unlock secrets of rare brain vessel diseases
Knowledge-focused Not yet recruitingThis study will collect blood samples and medical information from 600 adults with rare diseases affecting blood vessels in the brain and eye, such as CADASIL and cavernous angioma. The goal is to create a long-term biobank that researchers can use to find biomarkers and better u…
Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:00 UTC
-
Blood test may reveal hidden heart damage in AFib patients
Knowledge-focused Not yet recruitingThis study looks at 150 people with persistent atrial fibrillation (a type of irregular heartbeat) who are scheduled for a heart procedure called ablation. Researchers want to see if levels of a protein called BDNF in the blood are linked to signs of heart muscle damage (atrial c…
Sponsor: Centre Hospitalier Universitaire Dijon • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:00 UTC
-
Rare syndrome linked to higher post-transplant cancer risk – study aims to find out why
Knowledge-focused Not yet recruitingDenys-Drash syndrome is a rare genetic condition that causes kidney failure in early childhood, often requiring a transplant. Past research suggests these children have a much higher chance of developing a type of lymphoma after transplant compared to other kids. This study will …
Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:38 UTC
-
Could lynch syndrome raise your risk of gum disease?
Knowledge-focused Not yet recruitingThis study will check if people with Lynch syndrome, a genetic condition that raises cancer risk, have more gum disease than the general population. Researchers will look at dental records from 25 adults with Lynch syndrome. The goal is to see if gum disease is a hidden health is…
Sponsor: Rotundo Roberto • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:36 UTC
-
New online program aims to boost genetic cancer testing in african american families
Knowledge-focused Not yet recruitingThis study tests a web-based program called Kindred that helps African American families understand their genetic cancer risk and talk about testing. About 150 people will use the tool to see if it improves knowledge and testing rates. The goal is to make genetic information more…
Sponsor: University of Michigan Rogel Cancer Center • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:35 UTC
-
Can a simple walk test spot motor trouble in kids with NF1?
Knowledge-focused Not yet recruitingThis study looks at how young children with neurofibromatosis type 1 (NF1) walk, to see if simple walking tests can help doctors spot and predict movement problems early. Researchers will measure walking speed and other skills in 56 children under 6 years old. The goal is to crea…
Sponsor: NYU Langone Health • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:30 UTC
-
Could a greener anesthesia method be safer for your heart?
Knowledge-focused Not yet recruitingThis study looks at 128 adults having gallbladder surgery to see if using a low-flow (more eco-friendly) versus normal-flow sevoflurane anesthesia changes heart electrical signals linked to dangerous rhythms. Researchers will measure these signals before, during, and after surger…
Sponsor: Istanbul University • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:30 UTC
-
New drug interaction study launches for polycystic kidney disease treatment
Knowledge-focused Not yet recruitingThis early-stage study tests how a new drug called JMKX003142 interacts with other common medications in 112 healthy Chinese adults. The drug is being developed for autosomal dominant polycystic kidney disease (ADPKD). Researchers will measure how the body processes JMKX003142 wh…
Phase 1 • Sponsor: Jemincare • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:29 UTC
-
Can reusing heart catheters be safe and green? new study investigates
Knowledge-focused Not yet recruitingThis study looks at whether re-sterilized (reprocessed) catheters work as well as new ones for heart ablation procedures. About 200 adults needing this treatment will be randomly assigned to get either a new or a reprocessed catheter. Researchers will compare how long the procedu…
Sponsor: Ivan Zeljkovic • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:06 UTC
-
Rare syndrome study aims to map dental and facial patterns
Knowledge-focused Not yet recruitingThis study looks at the teeth, mouth, and face health of 25 people with Mowat-Wilson syndrome, a rare genetic condition. Researchers will check for cavities, gum disease, and facial features, and ask about quality of life. No treatment is given—the goal is to gather information t…
Sponsor: University of Milan • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:00 UTC
-
New study to measure daily life impact of rare bleeding disorder in youth
Knowledge-focused Not yet recruitingThis study looks at how hereditary hemorrhagic telangiectasia (HHT) affects the quality of life of children and young adults aged 2 to 25. Participants will fill out questionnaires about their physical, emotional, and social well-being. Researchers will also review medical record…
Sponsor: Ashley Nelson • Aim: Knowledge-focused
Last updated Jun 27, 2026 11:02 UTC
-
New Drug's heart effects under microscope in early safety trial
Knowledge-focused Not yet recruitingThis early-stage study checks whether a single dose of JMKX003142 affects the heart's electrical activity in 24 healthy Chinese adults. Participants will be randomly assigned to receive the drug or a placebo. The goal is to see if the drug causes any changes in heart rhythm, not …
Phase 1 • Sponsor: Jemincare • Aim: Knowledge-focused
Last updated Jun 27, 2026 11:01 UTC
-
Healthy men to help unravel how new kidney drug is processed
Knowledge-focused Not yet recruitingThis phase 1 trial will enroll 8 healthy Chinese men to study how the experimental drug JMKX003142 is absorbed, broken down, and eliminated from the body. Participants will receive the drug in both pill and IV forms, some with a radioactive tracer. The study aims to measure the d…
Phase 1 • Sponsor: Jemincare • Aim: Knowledge-focused
Last updated Jun 27, 2026 11:00 UTC
-
What keeps marfan patients from exercising? new study aims to find out
Knowledge-focused Not yet recruitingThis study will look at 118 adults with Marfan syndrome to understand why they may not be physically active. Researchers will measure factors like fear of movement, fatigue, pain, and heart health. The goal is to identify what predicts low activity levels, which could help improv…
Sponsor: University of Oviedo • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:06 UTC
-
1,100-Patient study aims to predict repeat heart ablation success
Knowledge-focused Not yet recruitingThis study will follow 1,100 people with atrial fibrillation who have a pulsed field ablation procedure. The goal is to find out which patient traits and procedure details make a repeat ablation more likely. Researchers will track heart rhythm problems and side effects for one ye…
Sponsor: Instituto de Investigación Sanitaria Aragón • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:51 UTC
-
New kidney drug interaction study launches in healthy volunteers
Knowledge-focused Not yet recruitingThis early-stage study tests how a new drug called JMKX003142 interacts with two common medications—amiodarone (for heart rhythm) and febuxostat (for gout)—in 48 healthy Chinese adults. Participants will take the drugs in sequence to measure how their bodies process them. The goa…
Phase 1 • Sponsor: Jemincare • Aim: Knowledge-focused
Last updated Jun 26, 2026 18:26 UTC
-
Researchers to examine bone density in rare genetic disorders
Knowledge-focused Not yet recruitingThis study will review medical records of 150 people with Marfan syndrome or Ehlers-Danlos syndrome to understand bone mineralization and fracture risk. Researchers will look at past bone density scans and health data to see how bone health changes over time. The goal is to learn…
Sponsor: IRCCS Policlinico S. Donato • Aim: Knowledge-focused
Last updated Jun 26, 2026 15:44 UTC